Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Quality Assessment of Dried Blood Spots from Tuberculosis Patients from Four Countries.

Zuur MA, Veenhof H, Aleksa A, Boveneind-Vrubleuskaya NV', Darmawan E, Hasnain MG, Heysell SK, Jongedijk EM, Koster RA, Magis-Escurra C, Martinez N, Molinas G, Mondal D, Mulyani UA, Perwitasari DA, Tsivunchyk A, Touw DJ, Alffenaar JC.

Ther Drug Monit. 2019 Jun 4. doi: 10.1097/FTD.0000000000000659. [Epub ahead of print]

PMID:
31169760
2.

Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant Tuberculosis.

Ghimire S, Maharjan B, Jongedijk EM, Kosterink JGW, Ghimire GR, Touw DJ, van der Werf TS, Shrestha B, Alffenaar JC.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02379-18. doi: 10.1128/AAC.02379-18. Print 2019 May.

PMID:
30782999
3.

Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients.

Ghimire S, Maharjan B, Jongedijk EM, Kosterink JGW, Ghimire GR, Touw DJ, van der Werf TS, Shrestha B, Alffenaar JC.

Eur Respir J. 2019 Apr 18;53(4). pii: 1802107. doi: 10.1183/13993003.02107-2018. Print 2019 Apr. No abstract available.

PMID:
30655280
4.

Simple and robust LC-MS/MS analysis method for therapeutic drug monitoring of micafungin.

Boonstra JM, Jongedijk EM, Koster RA, Touw DJ, Alffenaar JC.

Bioanalysis. 2018 Jun 1;10(11):877-886. doi: 10.4155/bio-2017-0275. Epub 2018 Jun 4.

PMID:
29863416
5.

Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.

Boonstra JM, van der Elst KC, Veringa A, Jongedijk EM, Br├╝ggemann RJ, Koster RA, Kampinga GA, Kosterink JG, van der Werf TS, Zijlstra JG, Touw DJ, Alffenaar JWC.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01398-17. doi: 10.1128/AAC.01398-17. Print 2017 Dec.

Supplemental Content

Loading ...
Support Center